
Sign up to save your podcasts
Or


Moderator:
Cat Burkat, MD FACS (Professor at Univ of Wisconsin-Madison)
Guests
· Dr. Elizabeth Bradley, Associate Professor at the Mayo Clinic, Rochester
· Dr. François Codère Associate Professor from the Université de Montréal in Canada
· Dr. Richard Allen, Professor at Baylor in Texas
In this Surgical Spotlight TOP podcast episode: "Myogenic Ptosis: Is It Really Any Different?", we are diving into a topic that most oculoplastic surgeons encounter—but rarely explore in depth: the surgical management of myogenic ptosis in progressive conditions such as Oculopharyngeal Muscular Dystrophy and Chronic Progressive External Ophthalmoplegia. We'll explore how the natural history of myogenic ptosis may change surgical decision-making. Should timing and the selected procedure be driven not just by the exam—but by disease trajectory? Does earlier onset signal a more aggressive course, pushing us toward more proactive surgery rather than a traditional stepwise approach? And how should we rethink concepts like recurrence, failure, and even surgical success when progression is expected?
Tune in as we discuss the challenge of correcting myogenic ptosis—for today, and where the patient will be years from now.
By The InBound Podcasting Network5
2727 ratings
Moderator:
Cat Burkat, MD FACS (Professor at Univ of Wisconsin-Madison)
Guests
· Dr. Elizabeth Bradley, Associate Professor at the Mayo Clinic, Rochester
· Dr. François Codère Associate Professor from the Université de Montréal in Canada
· Dr. Richard Allen, Professor at Baylor in Texas
In this Surgical Spotlight TOP podcast episode: "Myogenic Ptosis: Is It Really Any Different?", we are diving into a topic that most oculoplastic surgeons encounter—but rarely explore in depth: the surgical management of myogenic ptosis in progressive conditions such as Oculopharyngeal Muscular Dystrophy and Chronic Progressive External Ophthalmoplegia. We'll explore how the natural history of myogenic ptosis may change surgical decision-making. Should timing and the selected procedure be driven not just by the exam—but by disease trajectory? Does earlier onset signal a more aggressive course, pushing us toward more proactive surgery rather than a traditional stepwise approach? And how should we rethink concepts like recurrence, failure, and even surgical success when progression is expected?
Tune in as we discuss the challenge of correcting myogenic ptosis—for today, and where the patient will be years from now.

43,898 Listeners

32,100 Listeners

43,528 Listeners

38,856 Listeners

506 Listeners

2,446 Listeners

111,948 Listeners

56,508 Listeners

7,995 Listeners

50 Listeners

4,201 Listeners

19,524 Listeners

4,312 Listeners

19 Listeners